Roundup: ANDHealth receives $14M in gov’t funding, Zhongchao launches ovarian most cancers affected person administration platform and extra briefs

Australian digital well being backer ANDHealth scores $14M in authorities funding 

ANDHealth, a digital well being commercialisation organisation in Australia, has secured A$19.75 million ($14.3 million) in authorities funding to assist its programme for small and medium enterprises. It obtained the funding below the federal authorities’s Medical Analysis Future Fund – Early Stage Translation and Commercialisation Help programme.

In a press assertion, the group mentioned its new fund will usher within the enlargement of its ANDHealth+ programme that helps as much as 25 high-growth potential SMEs, that are picked by way of a aggressive course of. 

In line with ANDHealth CEO Bronwyn Le Grice, Australian digital well being corporations have solely raised a median capital quantity of roughly A$250,000 presently. 

Beneath the programme, the organisation is offering as much as A$1 million in funding, together with a devoted assist crew, entry to a c-suite trade advisory panel and specialised providers from pre-vetted suppliers.

“This programme will probably be transformational in offering funding of as much as $1 (million) per firm, alongside substantial assist and experience to speed up the scale-up of those life-changing applied sciences,” she mentioned. 

The ANDHealth+ programme has supported corporations utilizing applied sciences akin to computing platforms, connectivity, software program and sensors to deal with, diagnose, treatment, mitigate and stop ailments and different situations.

The organisation targets to open aggressive purposes for its expanded ANDHealth+ programme in September.

Zhongchao tapped for ovarian most cancers affected person administration in China

Chinese language healthcare platform supplier Zhongchao by its subsidiary Shanghai Zhongxin Medical Know-how Co. has supplied a affected person administration system to assist the therapy of ovarian most cancers sufferers in China.

The Zeyoulexiang Affected person Help Venture, which is managed by unbiased charity group Bethune Charitable Basis, is utilizing the Zhongchao platform to supply help to feminine sufferers taking the anti-cancer medicine Niraparib. 

Via the affected person administration system, sufferers can document, monitor and consider numerous indications of their our bodies and illness throughout medicine. They will additionally obtain early warnings of potential illness development to handle antagonistic reactions and psychological issues throughout medicine and enhance their adherence to therapy and therapy security. 

There’s additionally a follow-up characteristic within the system that permits docs to ship ​​one-on-one medicine steerage and way of life recommendation to sufferers to make sure appropriate medicine utilization and response to antagonistic reactions. 

The mentioned undertaking includes a community of greater than 350 hospitals, 40 pharmacies and round 1,000 physicians. It’s also collectively supported and assisted by the Most cancers Hospital Chinese language Academy of Medical Sciences, Beijing Obstetrics Gynecology Hospital, Peking Union Medical School Hospital, Beijing Most cancers Hospital, Zhongshan Hospital of Fudan College and Pink Home Hospital. Thus far, the undertaking has assisted over 5,000 ovarian most cancers sufferers. 

Zhongchao is coming into the ovarian most cancers market, which worth is anticipated to achieve $6.7 billion over the subsequent decade, in response to a forecast by GlobalData. In China, over 50,000 new ovarian most cancers circumstances and above 30,000 deaths had been recorded in 2018. 

Myanmar-based digital well being platform to supply free on-line well being consultations

HOPE Telecare, a digital well being platform in Myanmar, will probably be providing free digital medical consultations within the length of the nation’s lockdown. 

In a press release, the corporate is looking for volunteer docs to take part in its free telemedicine service.

Whereas it didn’t present a date for the free service launch, HOPE Telecare mentioned the telehealth service will probably be supplied to the general public by way of Fb Messenger and the HOPE cell app. 

Myanmar’s capital Yangon has been positioned below lockdown since July because of mounting COVID-19 infections. Reported circumstances within the nation had been round 384,000 with almost 15,000 deaths, as of late.

HOPE Telecare is a three way partnership by Burmese IT firm Blue Ocean Funding, co-founder Noticed Mra Aung and Malaysian telemedicine platform DOC2US of Heydoc Worldwide. 

mWell to launch digital medical mission 

Filipino cell well being and wellness app mWell by Metro Pacific Well being Tech is launching its nationwide medical mission on 28-29 August.

On the mentioned dates, the corporate will probably be offering its app customers and sufferers free physician consultations, waiving reserving and physician charges. In a press release, mWell is inviting docs and clinics throughout the nation to hitch its nationwide occasion.  

mWell is offering cell app-based providers, together with skilled consultations, medical analysis, care and therapy plans, in addition to personalised health, diet and wellness programmes and parenting options. 

It additionally runs e-pharmacy providers by native pharmacy South Star Drug and affords greater than 3,000 well being and wellness merchandise.

Supply hyperlink

What's your reaction?

In Love
Not Sure

You may also like

More in:Health

Leave a reply

Your email address will not be published. Required fields are marked *